Abstract
Lithium is an effective drug for both treatment and prophylaxis of affective disorder. The mechanism of lithium action is, however, still unknown. Over the past 50 years pre-clinical and clinical studies have focused upon the effects of both acute and chronic lithium on the regulation of neurotransmitter systems, especially the serotonergic system. In this chapter, current literature is reviewed in order to clarify the interactions of lithium with monoaminergic and cholinergic neurotransmitters.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.